文献

J-GLOBAL ID：201302220474558139   整理番号：13A0012647

尿酸代謝におけるロサルタン/ヒドロクロロチアジド併用降圧療法の効果

Effects of Combined Antihypertensive Therapy with Losartan/Hydrochlorothiazide on Uric Acid Metabolism

著者 (10件)： HOSOYA Tatsuo (Div. of Kidney and Hypertension, Jikei Univ. School of Medicine, JPN) ,  KURIYAMA Satoru (Div. of Kidney and Hypertension, Jikei Univ. School of Medicine, JPN) ,  KURIYAMA Satoru (Div. of Nephrology, Saiseikai Central Hospital, JPN) ,  YOSHIZAWA Takeo (Div. of Kidney and Hypertension, Jikei Univ. School of Medicine, JPN) ,  YOSHIZAWA Takeo (Div. of Nephrology, Saiseikai Central Hospital, JPN) ,  KOBAYASHI Akimitsu (Div. of Kidney and Hypertension, Jikei Univ. School of Medicine, JPN) ,  KOBAYASHI Akimitsu (Div. of Nephrology, Saiseikai Central Hospital, JPN) ,  OTSUKA Yasushi (Div. of Kidney and Hypertension, Jikei Univ. School of Medicine, JPN) ,  OTSUKA Yasushi (Div. of Nephrology, Saiseikai Central Hospital, JPN) ,  OHNO Iwao (Div. of Kidney and Hypertension, Jikei Univ. School of Medicine, JPN)
資料名： Internal Medicine (Web)  (Internal Medicine (Web))
巻： 51  号： 18  ページ： 2509-2514 (J-STAGE)  発行年： 2012年 
JST資料番号： U0033A  ISSN： 1349-7235  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： 目的:Jikei Optimal Antihypertens...

シソーラス用語： ヒト ,...
準シソーラス用語： JOINT Study

ログイン（無料）して見る     このテーマを更に深掘りする（JDreamⅢへ）  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=13A0012647&from=J-GLOBAL&jstjournalNo=U0033A") }}

分類 (1件)： 循環系疾患の薬物療法  (GJ05020M)

物質索引 (3件)： ロサルタン ,  尿酸 ,  ヒドロクロロチアジド

引用文献 (15件)：

• 1. Ogihara T, Kikuchi K, Matsuoka H, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 32: 3-107, 2009.
• 2. Chobanian AV, Bakris GL, Black HR, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee: the seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289: 2560-2572, 2003.
• 3. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2007 Guidelines for the management of arterial hypertension. Eur Heart J 28: 1462-1536, 2007.
• 4. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288: 2981-2997, 2002.
• 5. Kita T, Yokota N, Ichiki Y, et al. One-year effectiveness and safety of open-label losartan/hydrochlorothiazide combination therapy in Japanese patients with hypertension uncontrolled with ARBs or ACE inhibitors. Hypertension Research 33: 320-325, 2010.

タイトルに関連する用語 (5件)： 尿酸代謝 ,  ロサルタン ,  ヒドロクロロチアジド ,  併用 ,  降圧療法